Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium and Sertraline in Bipolar II Depression
NCT00276965Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Sep 2006
- Primary completion
- Mar 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lithium carbonate, sertraline in Bipolar II disorder (BP-II), major depressive disorder (MDD), sponsored by Lindner Center of HOPE. Started Sep 2006; status: completed.
02
Drugs
lithium carbonatesertraline
03
Conditions
Bipolar II disorder (BP-II)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00276965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276965.